The Pharmaceutical Benefits Scheme (PBS) recently made changes to the listings for proton pump inhibitors (PPIs) in an effort to address overprescribing.
The changes, which...
In the fourth of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the dispensing of repeat...
Treating bacterial infections without antibiotics might sound like a problem from another time, but it is a challenge that healthcare professionals in remote areas...
The evidence is in: positive health outcomes can hinge on patients’ ability to understand health information – and on pharmacists’ ability to impart it.
Health...
Research highlights the vital role HMRs play in averting medicine misadventure.
In 2016, members of the PSA Accredited Pharmacist Leadership Group (APLG) undertook an...
A recent study from the University of South Australia has highlighted the significant number of patients at risk of developing opioid dependence post-surgery, calling...
The discovery of sodium thiopental ushered in the era of modern intravenous anaesthesia, but its darker side as a ‘truth serum’ and use in...
Data from the Australian Bureau of Statistics (ABS) suggests that 13 million people have at least three risk factors for developing cardiovascular disease (CVD).1 A...
Arthritis Australia has launched a National Strategic Action Plan which resolves to prevent arthritis, invest in research, and improve treatment and support for people...
In Australia, prostate cancer is the most common type of cancer in males, with its prevalence increasing with age, but metformin may have a...
